CADL

Candel Therapeutics, Inc. - Common Stock (CADL)

About Candel Therapeutics, Inc. - Common Stock (CADL)

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Details

Daily high

$9.01

Daily low

$7.92

Price at open

$8.98

52 Week High

$14.00

52 Week Low

$4.35

Market cap

692.5M

Dividend yield

Volume

1.2M

Avg. volume

1.1M

P/E ratio

-6.42

Candel Therapeutics, Inc. - Common Stock News